Bulent Dabanlıoglu

5PUBLICATIONS
22CO-AUTHORS
Medical infection agents (incl. prions)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Food properties (incl. characteristics and health benefits)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 06, 2026
Alternative therapy against CTX-M broad spectrum β-lactamase resistance gene in Klebsiella pneumoniae infection: bee venom and bee venom-derived nanovesicle fraction.

|Jun 09, 2026
Oral microbiota member Neisseria elongata exosomes-Cassia fistula association targets PTEN/AKT/IL10/IL1β/BAX/BCL-2 signaling pathway in pancreatic cancer immunotherapy.

|Apr 30, 2026
Biotechnological application of Escherichia coli outer membrane vesicles for the delivery of Myristica fragrans phytochemicals in pancreatic cancer therapy.

|Feb 19, 2026
Determinate the effects of Arabic gum and Lactobacillus acidophilus on the gut microbiota ALPK1/NFKB/NLRP6 and NLRP2 signaling pathway and virulence gene profile in rats with Campylobacter jejuni exosome application.

Mahmut Ucar, Ozgur Celebi, Demet Celebi

|May 26, 2021
The protective effect of lycopene against oxidative kidney damage associated with combined use of isoniazid and rifampicin in rats.

F Bedir, H Kocaturk, O Turangezli

Pageof 1

Frequent Collaborators

4 joint publications

Sumeyye Baser

4 joint publications

Demet Celebi

4 joint publications

Ozgur Celebi

3 joint publications

Ali Taghizadehghalehjoughi